ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 7.80
-0.30 (-3.70%)
Nov 6, 2026, 5:00 PM CET
ViroGates Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 7.98 | 5.31 | 4.9 | 5.58 | 10.15 | 7.66 |
Other Revenue | 0.82 | 3.6 | 2.25 | 1.41 | 5.05 | 0.59 |
| 8.8 | 8.9 | 7.14 | 6.99 | 15.2 | 8.25 | |
Revenue Growth | 8.51% | 24.67% | 2.22% | -54.02% | 84.27% | 54.03% |
Cost of Revenue | 1.85 | 2.28 | 2.33 | 1.18 | 2.54 | 1.87 |
Gross Profit | 6.95 | 6.62 | 4.81 | 5.81 | 12.66 | 6.38 |
Selling, General & Admin | 8.78 | 8.95 | 12.46 | 11.93 | 12.92 | 18.64 |
Research & Development | 7.38 | 8.14 | 6.91 | 6.44 | 10.58 | 6.53 |
Operating Expenses | 16.16 | 17.09 | 19.37 | 18.37 | 23.5 | 25.17 |
Operating Income | -9.21 | -10.47 | -14.56 | -12.56 | -10.85 | -18.79 |
Interest Expense | -0.44 | -0.8 | -0.66 | -0.57 | -0.11 | -0.19 |
Interest & Investment Income | 0.05 | 0.05 | 0.04 | 0.04 | 0.08 | 0.02 |
Other Non Operating Income (Expenses) | 0.38 | -0 | - | -0 | -0 | -0 |
Pretax Income | -9.23 | -11.23 | -15.18 | -13.09 | -10.88 | -18.97 |
Income Tax Expense | -1.12 | -0.83 | -0.84 | -0.99 | -1.23 | -1.3 |
Net Income | -8.12 | -10.4 | -14.35 | -12.1 | -9.65 | -17.66 |
Net Income to Common | -8.12 | -10.4 | -14.35 | -12.1 | -9.65 | -17.66 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 8 | 7 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | - | 8 | 7 | 3 | 3 | 3 |
Shares Change | - | 18.54% | 92.52% | 6.33% | 3.23% | 2.30% |
EPS (Basic) | - | -1.32 | -2.15 | -3.49 | -2.96 | -5.60 |
EPS (Diluted) | - | -1.32 | -2.15 | -3.49 | -2.96 | -5.60 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -12.1 | -4.13 | -11.95 | -12.18 | -14.28 | -21.44 |
Free Cash Flow Per Share | - | -0.52 | -1.79 | -3.52 | -4.39 | -6.80 |
Gross Margin | 79.00% | 74.36% | 67.33% | 83.08% | 83.28% | 77.35% |
Operating Margin | -104.67% | -117.61% | -203.86% | -179.82% | -71.36% | -227.83% |
Profit Margin | -92.23% | -116.77% | -200.85% | -173.12% | -63.47% | -214.18% |
Free Cash Flow Margin | -137.53% | -46.33% | -167.28% | -174.31% | -93.94% | -259.94% |
EBITDA | - | - | -14.52 | -12.52 | -10.67 | -18.57 |
EBITDA Margin | - | - | -203.30% | -179.25% | -70.21% | -225.20% |
D&A For EBITDA | - | - | 0.04 | 0.04 | 0.18 | 0.22 |
EBIT | -9.21 | -10.47 | -14.56 | -12.56 | -10.85 | -18.79 |
EBIT Margin | -104.67% | -117.61% | -203.86% | -179.82% | -71.36% | -227.83% |